Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
49th Annual Meeting and Exposition of the American Society of Hematology
Extending Time to Progression in Refractory Multiple Myeloma with Novel Regimens
Atlanta, Georgia / December 8-11, 2007
Atlanta - After substantial progress in the development of more effective front-line therapies for multiple myeloma (MM), the standard for treatment of refractory disease is now also evolving. New findings indicate that meaningful...
49th Annual Meeting and Exposition of the American Society of Hematology
Clinical Challenges in Non-Hodgkin’s Lymphoma: The Use of Monoclonal Antibodies in 2008
Atlanta, Georgia / December 8-11, 2007
Studies presented at the American Society of Hematology reinforce the increasingly important role of therapies targeted at the CD20 surface protein in hematologic malignancies. In indolent non-Hodgkin’s lymphoma (NHL), final results of a...
FRONTLINE Based on presentations from the Eastern Ontario Gastrointestinal Stromal Tumours (GIST) Consensus Meeting
The Management of GIST: Achieving Consensus for Improved Care
Ottawa, Ontario / November 29, 2007
Reviewed by Shailendra Verma, MD, FRCPC Chair, Ottawa Regional Cancer Centre Ottawa General Hospital Assistant Professor of Medicine University of Ottawa Ottawa, Ontario Presenters Dr. Timothy Asmis Department of Oncology The Ottawa...
15th International Meeting of the European Society of Gynecological Oncology
Ovarian Cancer: Treatment Challenges and Decision-Making
Berlin, Germany / October 28-November 1, 2007
Berlin - Ovarian cancer remains the leading cause of death from gynecologic malignancies. Generally asymptomatic in its early stages, this disease is diagnosed in most women at advanced stages which correlate negatively with survival. While...
49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology
Glioblastoma Multiforme Prognosis: Improving Survival Rates
Los Angeles, California / October 28-November 1, 2007
Los Angeles -The most common brain tumour in adults, glioblastoma multiforme (GBM), accounts for almost half of all brain malignancies and has a 70% annual mortality. Few effective treatment options exist for GBM. Surgical resection...
15th United European Gastroenterology Week
Ulcerative Colitis: Maintenance of Remission and Prevention of Colorectal Cancer
Paris, France / October 27-31, 2007
Paris - In ulcerative colitis (UC), a pooled analysis of studies has associated 5-aminosalicylate (5-ASA) maintenance therapy with an almost 50% reduction in the risk of colorectal cancer. At least some of the protection provided can be...
EUROGIN 2007 7th International Multidisciplinary Congress
Clinical Implications of the New Quadrivalent Human Papillomavirus Vaccine
Monte Carlo, Monaco / October 4-6, 2007
As stated by Dr. Monika Hampl, University Hospital, Düsseldorf, Germany, “Cervical cancer is the second most common cause of cancer death among young women in Europe, and every year about 33,000 new cases are diagnosed.”...
14th European Cancer Conference (ECCO-14)
Targeting Multiple Molecular Pathways: A New Era in Oncology
Barcelona, Spain / September 23-27, 2007
Barcelona - Despite major strides in treating most forms of cancer over recent decades, liver cancer remains largely resistant to standard approaches. Current treatments for advanced hepatocellular carcinoma (HCC) are almost wholly...
47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Results from Follow-up Studies of the Quadrivalent Human Papillomavirus Vaccine: Continued Protection
Chicago, Illinois / September 17-20, 2007
The lifetime risk of sexually active men and women being infected with human papillomavirus (HPV) is at least 50% and in some settings, that risk is as high as 70%. Screening has dramatically reduced the incidence of cervical cancer, but it...